FRONTotemporal dementia Incidence European Research Study—FRONTIERS

Autor: Giancarlo Logroscino, Marco Piccininni, Barbara Borroni, James B. Rowe, Anne M. Remes, Orla Hardiman, Latchezar Traykov, Harro Seelaar, Albert C. Ludolph, Markus Otto, Elka Stefanova, Caroline Graff, Frontiers, Fermin Moreno
Přispěvatelé: Rowe, James [0000-0001-7216-8679], Apollo - University of Cambridge Repository
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Gerontology
medicine.medical_specialty
Referral
epidemiology [Frontotemporal Dementia]
registry
frontotemporal dementia
Cohort Studies
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Developmental Neuroscience
SDG 3 - Good Health and Well-being
Epidemiology
mental disorders
medicine
Humans
ddc:610
Prospective Studies
genetics [Frontotemporal Dementia]
Disease burden
epidemiology [Frontotemporal Lobar Degeneration]
030304 developmental biology
0303 health sciences
business.industry
Health Policy
Incidence (epidemiology)
Incidence
nutritional and metabolic diseases
rare diseases
Frontotemporal lobar degeneration
medicine.disease
3. Good health
nervous system diseases
Psychiatry and Mental health
frontotemporal lobar degeneration
Frontotemporal Dementia
Population study
Observational study
epidemiology
Neurology (clinical)
genetics [Frontotemporal Lobar Degeneration]
Geriatrics and Gerontology
business
030217 neurology & neurosurgery
Frontotemporal dementia
Zdroj: Alzheimer's and dementia 18(3), 498-506 (2022). doi:10.1002/alz.12414
ISSN: 1552-5260
Popis: Introduction The incidence of Frontotemporal Lobar Degeneration (FTLD)-related disorders and their characteristics are not well known. The "FRONTotemporal dementia Incidence European Research Study" (FRONTIERS) is designed to fill this gap. Methods FRONTIERS is a European prospective, observational population study based on multinational registries. FRONTIERS comprises 11 tertiary referral centers across Europe with long-lasting experience in FTLD-related disorders and comprehensive regional referral networks, enabling incidence estimation over well-defined geographical areas. Endpoints The primary endpoints are (1) the incidence of FTLD-related disorders across Europe; (2) geographic trends of FTLD-related disorders; (3) the distribution of FTLD phenotypes in different populations and ethnicities in Europe; (4) inheritance of FTLD-related disorders, including the frequencies of monogenic FTLD as compared to overall disease burden; and (5) implementation of data banking for clinical and biological material. Expected impacts FRONTIERS will improve the understanding of FTLD-related disorders and their epidemiology, promoting appropriate public health service policies and treatment strategies.
Databáze: OpenAIRE